pentobarbital will decrease the extent or outcome of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Use of other therapies is strongly encouraged when linagliptin is usually to be administered which has a CYP3A4 inducer pentobarbital will reduce t